We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

17 hedge funds and large institutions have $208K invested in Bio-Path Holdings Inc in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

35% less funds holding

Funds holding: 26 → 17 (-9)

81% less capital invested

Capital invested by funds: $1.1M → $208K (-$890K)

90% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 10

Holders
17
Holders Change
-9
Holders Change %
-34.62%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$102K
2
TSS
Two Sigma Securities
New York
+$6.86K
3
BlackRock
BlackRock
New York
+$343

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$437K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$21K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$19K
4
SFS
Sowell Financial Services
Arkansas
-$18K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$13.6K

BPTH Hedge Fund Activity: Q4 2018 in Review

17 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q4 2018, worth a combined $208K — down 81% from $1.1M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of BPTH and 1 opened new positions — a net loss of 9 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $102K. The largest seller was Sabby Management, exiting entirely with an estimated $437K sold.

  • 17 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q4 2018, down from 26 in Q3 2018.
  • Funds reported $208K of Bio-Path Holdings Inc stock for Q4 2018, down 81% quarter-over-quarter.
  • 1 fund opened new Bio-Path Holdings Inc positions in Q4 2018 and 10 closed out, a net change of -9 holders.
  • The largest Bio-Path Holdings Inc buyer in Q4 2018 was Renaissance Technologies, an estimated $102K added.
  • The largest Bio-Path Holdings Inc seller in Q4 2018 was Sabby Management, an estimated $437K sold.

Based on aggregated 13F filings for Q4 2018.